2016 Grand Rounds Video Archive

May 31, 2016: Scott M. Lippman, MD - Mapping Premalignant Biology to Drive Precision Prevention and Vaccines

May 24, 2016: Sidi Chen, PhD - In vivo genome editing in cancer modeling and screening

May 24, 2016: Andre Levchenko, PhD - Using nano-technology to predict patient outcomes and find new therapeutic targets

May 17, 2016: Shi-Yi Wang, MD, PhD - Geographic Variation in End-of-Life Care: Insights from Health Services Research

May 10, 2016: Richard White, MD, PhD - Illuminating Metastasis: Insights from Zebrafish Cancer Models

April 26, 2016: Nicole Ullrich, MD, PhD - Neurologic Complications of Childhood Cancer

April 26, 2016: Linda Niccolai, PhD - HPV Vaccination: The Role of Clinicians in Promoting Higher Uptake

April 12, 2016: Natalia Issaeva, PhD - Functional Interaction Between PARP & HPV Capsid

March 29, 2016: Shrikant Mane, PhD - Genomic and Proteomic Technologies available and their applications to biomedical research

March 29, 2016: Jeffrey Townsend, PhD - Multiple Origins of Metastatic Lineages within Primary Tumors

March 15, 2016: Jonathan Chernoff, MD, PhD - p-21 Activated Kinases as Therapeutic Targets in Breast Cancer

March 1, 2016: Rami S. Komrokji, MD - Myelodysplastic Syndromes: Current Standards and Future Directions

February 23, 2016: Michael Green, MD, PhD - Discovery of Oncoprotein-Directed Regulatory Pathways using Functional Genomics

February 16, 2016: Max S. Wicha, MD - Targeting Breast Cancer Stem Cells

February 9, 2016: William Hurt Sledge, MD - Recognizing Suicidal Risks and What to do about them in the Medical Setting

February 2, 2016: Steven Katz, MD, MPH - The Impact of Precision Medicine on Cancer Treatment Decisions: Insights from Encounters with Breast Cancer

January 26, 2016: Lynn Tanoue, MD - Lung Cancer Screening

January 19, 2016: Janie Merkl, PhD - From Disease Hypothesis to Treatment Prototype: Program in Innovative Therapeutics for CT's Health (PITCH) and The Yale Center for Molecular Discovery

January 5, 2016: James H. Doroshow, MD - Role of Proof of Mechanism Pharmacodynamic Studies in Cancer Drug Development